BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1240 related articles for article (PubMed ID: 33147627)

  • 1. Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research.
    Hufsky F; Lamkiewicz K; Almeida A; Aouacheria A; Arighi C; Bateman A; Baumbach J; Beerenwinkel N; Brandt C; Cacciabue M; Chuguransky S; Drechsel O; Finn RD; Fritz A; Fuchs S; Hattab G; Hauschild AC; Heider D; Hoffmann M; Hölzer M; Hoops S; Kaderali L; Kalvari I; von Kleist M; Kmiecinski R; Kühnert D; Lasso G; Libin P; List M; Löchel HF; Martin MJ; Martin R; Matschinske J; McHardy AC; Mendes P; Mistry J; Navratil V; Nawrocki EP; O'Toole ÁN; Ontiveros-Palacios N; Petrov AI; Rangel-Pineros G; Redaschi N; Reimering S; Reinert K; Reyes A; Richardson L; Robertson DL; Sadegh S; Singer JB; Theys K; Upton C; Welzel M; Williams L; Marz M
    Brief Bioinform; 2021 Mar; 22(2):642-663. PubMed ID: 33147627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 CG enables SARS-CoV-2 mutation and lineage tracking by locations and dates of interest.
    Chen AT; Altschuler K; Zhan SH; Chan YA; Deverman BE
    Elife; 2021 Feb; 10():. PubMed ID: 33620031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analyses of bioinformatics applications in the fight against COVID-19 pandemic.
    Ma L; Li H; Lan J; Hao X; Liu H; Wang X; Huang Y
    Comput Biol Chem; 2021 Dec; 95():107599. PubMed ID: 34773807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics resources for SARS-CoV-2 discovery and surveillance.
    Hu T; Li J; Zhou H; Li C; Holmes EC; Shi W
    Brief Bioinform; 2021 Mar; 22(2):631-641. PubMed ID: 33416890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topological Analysis for Sequence Variability: Case Study on more than 2K SARS-CoV-2 sequences of COVID-19 infected 54 countries in comparison with SARS-CoV-1 and MERS-CoV.
    Sarkar JP; Saha I; Seal A; Maity D; Maulik U
    Infect Genet Evol; 2021 Mar; 88():104708. PubMed ID: 33421654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics resources facilitate understanding and harnessing clinical research of SARS-CoV-2.
    Ahsan MA; Liu Y; Feng C; Zhou Y; Ma G; Bai Y; Chen M
    Brief Bioinform; 2021 Mar; 22(2):714-725. PubMed ID: 33432321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronavirus discovery by metagenomic sequencing: a tool for pandemic preparedness.
    Carbo EC; Sidorov IA; Zevenhoven-Dobbe JC; Snijder EJ; Claas EC; Laros JFJ; Kroes ACM; de Vries JJC
    J Clin Virol; 2020 Oct; 131():104594. PubMed ID: 32866812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far.
    Khan M; Adil SF; Alkhathlan HZ; Tahir MN; Saif S; Khan M; Khan ST
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33374759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-generation computational tools and resources for coronavirus research: From detection to vaccine discovery.
    Kangabam R; Sahoo S; Ghosh A; Roy R; Silla Y; Misra N; Suar M
    Comput Biol Med; 2021 Jan; 128():104158. PubMed ID: 33301953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision Response to the Rise of the SARS-CoV-2 B.1.1.7 Variant of Concern by Combining Novel PCR Assays and Genome Sequencing for Rapid Variant Detection and Surveillance.
    Zelyas N; Pabbaraju K; Croxen MA; Lynch T; Buss E; Murphy SA; Shokoples S; Wong A; Kanji JN; Tipples G
    Microbiol Spectr; 2021 Sep; 9(1):e0031521. PubMed ID: 34378966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19: Discovery, diagnostics and drug development.
    Asselah T; Durantel D; Pasmant E; Lau G; Schinazi RF
    J Hepatol; 2021 Jan; 74(1):168-184. PubMed ID: 33038433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 HaploGraph: visualization of SARS-CoV-2 haplotype spread in Japan.
    Nakagawa S; Katayama T; Jin L; Wu J; Kryukov K; Oyachi R; Takeuchi JS; Fujisawa T; Asano S; Komatsu M; Onami JI; Abe T; Arita M
    Genes Genet Syst; 2023 Nov; 98(5):221-237. PubMed ID: 37839865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2, the pandemic coronavirus: Molecular and structural insights.
    Kadam SB; Sukhramani GS; Bishnoi P; Pable AA; Barvkar VT
    J Basic Microbiol; 2021 Mar; 61(3):180-202. PubMed ID: 33460172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A main event and multiple introductions of SARS-CoV-2 initiated the COVID-19 epidemic in Greece.
    Spanakis N; Kassela K; Dovrolis N; Bampali M; Gatzidou E; Kafasi A; Froukala E; Stavropoulou A; Lilakos K; Veletza S; Tsiodras S; Tsakris A; Karakasiliotis I
    J Med Virol; 2021 May; 93(5):2899-2907. PubMed ID: 33410223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA Viromics of Southern California Wastewater and Detection of SARS-CoV-2 Single-Nucleotide Variants.
    Rothman JA; Loveless TB; Kapcia J; Adams ED; Steele JA; Zimmer-Faust AG; Langlois K; Wanless D; Griffith M; Mao L; Chokry J; Griffith JF; Whiteson KL
    Appl Environ Microbiol; 2021 Nov; 87(23):e0144821. PubMed ID: 34550753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation on the use of Nanopore sequencing for direct characterization of coronaviruses from respiratory specimens, and a study on emerging missense mutations in partial RdRP gene of SARS-CoV-2.
    Chan WS; Au CH; Lam HY; Wang CLN; Ho DN; Lam YM; Chu DKW; Poon LLM; Chan TL; Zee JS; Ma ESK; Tang BSF
    Virol J; 2020 Nov; 17(1):183. PubMed ID: 33225958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A brief molecular insight of COVID-19: epidemiology, clinical manifestation, molecular mechanism, cellular tropism and immuno-pathogenesis.
    Singh S; Pandey R; Tomar S; Varshney R; Sharma D; Gangenahalli G
    Mol Cell Biochem; 2021 Nov; 476(11):3987-4002. PubMed ID: 34195882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics for the Origin and Evolution of Viruses.
    Chen J; Zhang Y; Shen B
    Adv Exp Med Biol; 2022; 1368():53-71. PubMed ID: 35594020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.